» Articles » PMID: 16890604

The Role of Tumor Necrosis Factor Alpha in Down-regulation of Osteoblast Phex Gene Expression in Experimental Murine Colitis

Overview
Specialty Gastroenterology
Date 2006 Aug 8
PMID 16890604
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Reduced bone mass is a common complication of inflammatory bowel disease (IBD), although the mechanisms that contribute to osteopenia are not completely understood. Tumor necrosis factor alpha (TNF-alpha) is up-regulated in patients with IBD and has detrimental effects on osteoblasts. Phex gene is expressed predominantly in osteoblasts, and its disruption results in defective bone mineralization. The aim of this study was to evaluate whether TNF-alpha regulates Phex gene expression thus contributing to the abnormal bone metabolism observed in IBD.

Methods: Phex gene expression was evaluated in calvaria of 6-7-week-old mice administered with trinitrobenzene sulfonic acid (TNBS) with or without neutralizing anti-TNF-alpha antibody, dietary curcumin, or systemically with recombinant TNF-alpha. TNF-alpha-treated UMR-106 osteoblasts were also examined. Phex promoter activity was assayed in transiently transfected TNF-alpha-treated UMR-106 cells.

Results: Compared with control animals, Phex messenger RNA (mRNA) expression decreased by 40%-50% in both TNBS colitis and TNF-alpha-injected mice. Dietary curcumin and anti-TNF-alpha antibody counteracted the detrimental effect of TNBS on Phex gene expression. TNF-alpha-treated UMR-106 cells showed a concentration-dependent and transcriptionally mediated decrease in Phex mRNA and gene promoter activity, with the -133 to -74 bp region of the Phex promoter likely involved in the mechanism of TNF-alpha action. Coinciding with decreased Phex protein level, TNF-alpha drastically reduced mineralization in UMR-106 osteoblasts.

Conclusions: Acute colitis and TNF-alpha decrease Phex mRNA and protein expression via a transcriptional mechanism. TNF-alpha-mediated reduction in Phex protein is at least in part responsible for inhibition of osteoblast mineralization, and the described mechanism may contribute to the abnormal bone metabolism associated with IBD.

Citing Articles

Low Bone Turnover, Mineralization Impairment, and Cortical Alterations in Patients with Axial Spondyloarthritis: A Histomorphometric Study.

Machado N, Pinheiro M, Chula D, Ceron R, Pinheiro F, Serrato V Calcif Tissue Int. 2025; 116(1):17.

PMID: 39751834 DOI: 10.1007/s00223-024-01314-0.


Acute Kidney Injury and Pediatric Bone Health.

Hegde A, Denburg M, Glenn D Front Pediatr. 2021; 8:635628.

PMID: 33634055 PMC: 7900149. DOI: 10.3389/fped.2020.635628.


Bone Health in Glomerular Kidney Disease.

Glenn D, Denburg M Curr Osteoporos Rep. 2019; 17(6):570-579.

PMID: 31734906 PMC: 7153693. DOI: 10.1007/s11914-019-00531-z.


Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations.

Lederer E, Wagner C Pflugers Arch. 2018; 471(1):137-148.

PMID: 30542787 DOI: 10.1007/s00424-018-2246-5.


Expression of Cav1.3 calcium channel in the human and mouse colon: posttranscriptional inhibition by IFNγ.

Radhakrishnan V, Gilpatrick M, Parsa N, Kiela P, Ghishan F Am J Physiol Gastrointest Liver Physiol. 2016; 312(1):G77-G84.

PMID: 27932504 PMC: 5283901. DOI: 10.1152/ajpgi.00394.2016.